CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net Income (Loss)	$ (4,801)	$ (9,043)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,030	697
Stock-based compensation expense	1,629	2,235
Credit loss, net of recoveries	460	2,350
(Gain) loss on disposition of assets	(2)	63
Noncash amortization of debt discount	436	409
Noncash change in fair value of derivatives	(42)	(295)
Other	(1)	(1)
Changes in operating assets and liabilities:
Accounts receivable	253	(2,461)
Prepaid expenses and other current assets	1,162	(467)
Accounts payable	(246)	(16)
Accrued expenses and other current liabilities	(205)	(3,246)
Deferred revenue	11	137
Net cash used in operating activities	(316)	(9,638)
Cash flows from investing activities
Additions of property, equipment, and software	(1,080)	(1,042)
Proceeds from sale of property and equipment	2	27
Net cash used in investing activities	(1,078)	(1,015)
Cash flows from financing activities
Issuance of common Stock under ESPP	24	168
Tax payments related to shares retired for vested restricted stock units	(68)	0
Repayments of related party payables	(90)	1
Net proceeds from sale of stock via ATM Offering	908	0
Repayments of short-term financing arrangements	(1,109)	0
Net cash (used in) provided by financing activities	(335)	169
Net decrease in cash, cash equivalents, and restricted cash	(1,729)	(10,484)
Cash, cash equivalents, and restricted cash, beginning of period	15,544	25,202
Cash, cash equivalents, and restricted cash, end of period	13,815	14,718
Supplemental disclosure of non-cash financing activities
Short-term financing of insurance payable	1,399	0
Conversion of promissory notes into common stock	$ 292	$ 0